News Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
20.87 ^USD	+1.51%		-1.37%	-42.57%

Mar. 04	Prothena Names David Ford as Chief People Officer	MT
Mar. 04	Prothena Appoints David Ford to Newly Created Chief People Officer	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia and Lymphoma	Apr. 16	AQ
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma	Apr. 15	BU
Prothena : Director's Report and Financial Statements for Fiscal Year 2023	Mar. 29	PU
Prothena to Participate in Upcoming Healthcare Conferences	Mar. 05	BU
Prothena Names David Ford as Chief People Officer	Mar. 04	MT
Prothena Appoints David Ford to Newly Created Chief People Officer Position	Mar. 04	BU
Prothena Appoints David Ford to Newly Created Chief People Officer	Mar. 04	CI
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate	Feb. 21	BU
Prothena Corporation plc Announces Board Changes	Feb. 21	CI
Oppenheimer Cuts Prothena Price Target to $80 From $98, Maintains Outperform Rating	Feb. 20	MT
Sector Update: Health Care Stocks Gain Pre-Bell Friday	Feb. 16	MT
RBC Trims Price Target on Prothena to $35 From $36, Keeps Sector Perform, Speculative Risk	Feb. 16	MT
Prothena Posts Q4 Net Loss as Revenue Slumps	Feb. 15	MT
Prothena: Q4 Earnings Snapshot	Feb. 15	AQ
Earnings Flash (PRTA) PROTHENA CORPORATION Reports Q4 Revenue $316,000, vs. Street Est of $2.72M	Feb. 15	MT
Prothena Corporation plc Provides Earnings Guidance for the Year 2024	Feb. 15	CI
Transcript : Prothena Corporation plc, Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
Prothena Corporation plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights	Feb. 15	BU
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024	Feb. 08	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Summary

Filters